Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
Contact Us
Versions and log file
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
ATAZANAVIR SULFATE
(2003)
Small molecule
Human immunodeficiency virus type 1 protease inhibitor
ORAL
Approved
HIV Infections; Infections
ATAZANAVIR SULFATE
×
Maximum Phase:
4
First Approval:
2003
UNII:
4MT4VIE29P
Molecule Type:
Small molecule
Molecular Formula:
C38H54N6O11S
Molecular Weight:
802.95
AlogP:
4.21
PSA:
171.22
HBD:
5.0
HBA:
#RotB:
14.0
Source:
CARBINOXAMINE MALEATE
(2003)
Small molecule
Histamine H1 receptor antagonist
ORAL
Approved
Angioedema; Conjunctivitis, Allergic; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Rhinitis, Vasomotor; Urticaria
CARBINOXAMINE MALEATE
×
Maximum Phase:
4
First Approval:
2003
UNII:
02O55696WH
Molecule Type:
Small molecule
Molecular Formula:
C20H23ClN2O5
Molecular Weight:
406.87
AlogP:
3.4
PSA:
25.36
HBD:
0.0
HBA:
#RotB:
6.0
Source:
GEMIFLOXACIN
(2003)
Small molecule
Unknown
Unknown
Approved
Bacterial Infections
GEMIFLOXACIN
×
Maximum Phase:
4
First Approval:
2003
UNII:
OKR68Y0E4T
Molecule Type:
Small molecule
Molecular Formula:
C18H20FN5O4
Molecular Weight:
389.39
AlogP:
0.97
PSA:
123.04
HBD:
2.0
HBA:
#RotB:
5.0
Source:
ALFUZOSIN HYDROCHLORIDE
(2003)
Small molecule
Adrenergic receptor alpha-1 agonist
ORAL
Approved
Prostatic Hyperplasia
ALFUZOSIN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2003
UNII:
75046A1XTN
Molecule Type:
Small molecule
Molecular Formula:
C19H28ClN5O4
Molecular Weight:
425.92
AlogP:
1.35
PSA:
111.83
HBD:
2.0
HBA:
#RotB:
8.0
Source:
VARDENAFIL HYDROCHLORIDE
(2003)
Small molecule
Phosphodiesterase 5A inhibitor
ORAL
Approved
Erectile Dysfunction
VARDENAFIL HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2003
UNII:
IF61NL91H3
Molecule Type:
Small molecule
Molecular Formula:
C23H33ClN6O4S
Molecular Weight:
525.08
AlogP:
2.07
PSA:
112.9
HBD:
1.0
HBA:
#RotB:
8.0
Source:
ALFUZOSIN
(2003)
Small molecule
Unknown
Unknown
Approved
Prostatic Hyperplasia
ALFUZOSIN
×
Maximum Phase:
4
First Approval:
2003
UNII:
90347YTW5F
Molecule Type:
Small molecule
Molecular Formula:
C19H27N5O4
Molecular Weight:
389.46
AlogP:
1.35
PSA:
111.83
HBD:
2.0
HBA:
#RotB:
8.0
Source:
SERTACONAZOLE NITRATE
(2003)
Small molecule
Cytochrome P450 51 inhibitor
TOPICAL
Approved
Tinea Pedis
SERTACONAZOLE NITRATE
×
Maximum Phase:
4
First Approval:
2003
UNII:
1DV05410M5
Molecule Type:
Small molecule
Molecular Formula:
C20H16Cl3N3O4S
Molecular Weight:
500.79
AlogP:
7.02
PSA:
27.05
HBD:
0.0
HBA:
#RotB:
6.0
Source:
ROSUVASTATIN
(2003)
Small molecule
Unknown
Unknown
Approved
Cardiovascular Diseases
ROSUVASTATIN
×
Maximum Phase:
4
First Approval:
2003
UNII:
413KH5ZJ73
Molecule Type:
Small molecule
Molecular Formula:
C22H28FN3O6S
Molecular Weight:
481.55
AlogP:
2.4
PSA:
140.92
HBD:
3.0
HBA:
#RotB:
10.0
Source:
MEMANTINE HYDROCHLORIDE
(2003)
Small molecule
Glutamate [NMDA] receptor negative allosteric modulator
ORAL
Approved
Alzheimer Disease; Dementia
MEMANTINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2003
UNII:
JY0WD0UA60
Molecule Type:
Small molecule
Molecular Formula:
C12H22ClN
Molecular Weight:
215.77
AlogP:
2.69
PSA:
26.02
HBD:
1.0
HBA:
#RotB:
0.0
Source:
IBANDRONATE SODIUM
(2003)
Small molecule
Farnesyl diphosphate synthase inhibitor
INJECTION; INTRAVENOUS; ORAL
Approved
Osteoporosis; Osteoporosis, Postmenopausal
IBANDRONATE SODIUM
×
Maximum Phase:
4
First Approval:
2003
UNII:
J12U072QL0
Molecule Type:
Small molecule
Molecular Formula:
C9H24NNaO8P2
Molecular Weight:
359.23
AlogP:
0.5
PSA:
138.53
HBD:
5.0
HBA:
#RotB:
9.0
Source:
VARDENAFIL
(2003)
Small molecule
Unknown
Unknown
Approved
Erectile Dysfunction
VARDENAFIL
×
Maximum Phase:
4
First Approval:
2003
UNII:
UCE6F4125H
Molecule Type:
Small molecule
Molecular Formula:
C23H32N6O4S
Molecular Weight:
488.61
AlogP:
2.07
PSA:
112.9
HBD:
1.0
HBA:
#RotB:
8.0
Source:
MIGLUSTAT
(2003)
Small molecule
Ceramide glucosyltransferase inhibitor
ORAL
Approved
Gaucher Disease
MIGLUSTAT
×
Maximum Phase:
4
First Approval:
2003
UNII:
ADN3S497AZ
Molecule Type:
Small molecule
Molecular Formula:
C10H21NO4
Molecular Weight:
219.28
AlogP:
-1.45
PSA:
84.16
HBD:
4.0
HBA:
#RotB:
4.0
Source:
SERTACONAZOLE
(2003)
Small molecule
Unknown
Unknown
Approved
Unknown
SERTACONAZOLE
×
Maximum Phase:
4
First Approval:
2003
UNII:
72W71I16EG
Molecule Type:
Small molecule
Molecular Formula:
C20H15Cl3N2OS
Molecular Weight:
437.78
AlogP:
7.02
PSA:
27.05
HBD:
0.0
HBA:
#RotB:
6.0
Source:
FOSAMPRENAVIR
(2003)
Small molecule
Unknown
Unknown
Approved
Virus Diseases
FOSAMPRENAVIR
×
Maximum Phase:
4
First Approval:
2003
UNII:
WOU1621EEG
Molecule Type:
Small molecule
Molecular Formula:
C25H36N3O9PS
Molecular Weight:
585.62
AlogP:
2.52
PSA:
177.72
HBD:
4.0
HBA:
#RotB:
13.0
Source:
PALONOSETRON
(2003)
Small molecule
Unknown
Unknown
Approved
Nausea
PALONOSETRON
×
Maximum Phase:
4
First Approval:
2003
UNII:
5D06587D6R
Molecule Type:
Small molecule
Molecular Formula:
C19H24N2O
Molecular Weight:
296.41
AlogP:
2.66
PSA:
23.55
HBD:
0.0
HBA:
#RotB:
1.0
Source:
ESTRADIOL ACETATE
(2003)
Small molecule
Estrogen receptor alpha agonist
ORAL; VAGINAL
Approved
Atrophy; Menopause
ESTRADIOL ACETATE
×
Maximum Phase:
4
First Approval:
2003
UNII:
5R97F5H93P
Molecule Type:
Small molecule
Molecular Formula:
C20H26O3
Molecular Weight:
314.43
AlogP:
3.83
PSA:
46.53
HBD:
1.0
HBA:
#RotB:
1.0
Source:
BORTEZOMIB
(2003)
Small molecule
26S proteosome inhibitor
INJECTION; INTRAVENOUS; SUBCUTANEOUS; UNKNOWN
Approved
Lymphoma, Mantle-Cell; Multiple Myeloma; Neoplasms
BORTEZOMIB
×
Maximum Phase:
4
First Approval:
2003
UNII:
69G8BD63PP
Molecule Type:
Small molecule
Molecular Formula:
C19H25BN4O4
Molecular Weight:
384.25
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
OMEPRAZOLE MAGNESIUM
(2003)
Small molecule
Potassium-transporting ATPase inhibitor
Unknown
Approved
Unknown
OMEPRAZOLE MAGNESIUM
×
Maximum Phase:
4
First Approval:
2003
UNII:
426QFE7XLK
Molecule Type:
Small molecule
Molecular Formula:
C34H36MgN6O6S2
Molecular Weight:
713.14
AlogP:
2.9
PSA:
77.1
HBD:
1.0
HBA:
#RotB:
5.0
Source:
MEMANTINE
(2003)
Small molecule
Unknown
Unknown
Approved
Dementia
MEMANTINE
×
Maximum Phase:
4
First Approval:
2003
UNII:
W8O17SJF3T
Molecule Type:
Small molecule
Molecular Formula:
C12H21N
Molecular Weight:
179.31
AlogP:
2.69
PSA:
26.02
HBD:
1.0
HBA:
#RotB:
0.0
Source:
GEFITINIB
(2003)
Small molecule
Epidermal growth factor receptor erbB1 inhibitor
ORAL
Approved
Carcinoma, Non-Small-Cell Lung; Neoplasms
GEFITINIB
×
Maximum Phase:
4
First Approval:
2003
UNII:
S65743JHBS
Molecule Type:
Small molecule
Molecular Formula:
C22H24ClFN4O3
Molecular Weight:
446.91
AlogP:
4.28
PSA:
68.74
HBD:
1.0
HBA:
#RotB:
8.0
Source:
EMTRICITABINE
(2003)
Small molecule
Human immunodeficiency virus type 1 reverse transcriptase inhibitor
ORAL
Approved
HIV Infections; Virus Diseases
EMTRICITABINE
×
Maximum Phase:
4
First Approval:
2003
UNII:
ULS8902U4O
Molecule Type:
Small molecule
Molecular Formula:
C8H10FN3O3S
Molecular Weight:
247.25
AlogP:
-0.46
PSA:
90.37
HBD:
2.0
HBA:
#RotB:
2.0
Source:
GEMIFLOXACIN MESYLATE
(2003)
Small molecule
DNA gyrase inhibitor
ORAL
Approved
Unknown
GEMIFLOXACIN MESYLATE
×
Maximum Phase:
4
First Approval:
2003
UNII:
X4S9F8RL01
Molecule Type:
Small molecule
Molecular Formula:
C19H24FN5O7S
Molecular Weight:
485.49
AlogP:
0.97
PSA:
123.04
HBD:
2.0
HBA:
#RotB:
5.0
Source:
PRUSSIAN BLUE INSOLUBLE
(2003)
Small molecule
Radioactive metals chelating agent
Unknown
Approved
Unknown
PRUSSIAN BLUE INSOLUBLE
×
Maximum Phase:
4
First Approval:
2003
UNII:
TLE294X33A
Molecule Type:
Small molecule
Molecular Formula:
C18Fe7N18
Molecular Weight:
859.24
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ROSUVASTATIN CALCIUM
(2003)
Small molecule
HMG-CoA reductase inhibitor
ORAL
Approved
Atherosclerosis; Coronary Artery Disease; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III
ROSUVASTATIN CALCIUM
×
Maximum Phase:
4
First Approval:
2003
UNII:
83MVU38M7Q
Molecule Type:
Small molecule
Molecular Formula:
C44H54CaF2N6O12S2
Molecular Weight:
1001.15
AlogP:
2.4
PSA:
140.92
HBD:
3.0
HBA:
#RotB:
10.0
Source:
CARBINOXAMINE
(2003)
Small molecule
Unknown
Unknown
Approved
Hypersensitivity
CARBINOXAMINE
×
Maximum Phase:
4
First Approval:
2003
UNII:
982A7M02H5
Molecule Type:
Small molecule
Molecular Formula:
C16H19ClN2O
Molecular Weight:
290.79
AlogP:
3.4
PSA:
25.36
HBD:
0.0
HBA:
#RotB:
6.0
Source:
METHYL AMINOLEVULINATE
(2004)
Small molecule
Unknown
Unknown
Approved
Neoplasms
METHYL AMINOLEVULINATE
×
Maximum Phase:
4
First Approval:
2004
UNII:
585NM85KYM
Molecule Type:
Small molecule
Molecular Formula:
C6H11NO3
Molecular Weight:
145.16
AlogP:
-0.53
PSA:
69.39
HBD:
1.0
HBA:
#RotB:
4.0
Source:
DARIFENACIN HYDROBROMIDE
(2004)
Small molecule
Muscarinic acetylcholine receptor M2 antagonist
ORAL
Approved
Urinary Bladder, Overactive; Urinary Incontinence, Urge
DARIFENACIN HYDROBROMIDE
×
Maximum Phase:
4
First Approval:
2004
UNII:
CR02EYQ8GV
Molecule Type:
Small molecule
Molecular Formula:
C28H31BrN2O2
Molecular Weight:
507.47
AlogP:
3.96
PSA:
55.56
HBD:
1.0
HBA:
#RotB:
7.0
Source:
ACAMPROSATE CALCIUM
(2004)
Small molecule
GABA-A receptor; anion channel positive modulator
ORAL
Approved
Alcoholism
ACAMPROSATE CALCIUM
×
Maximum Phase:
4
First Approval:
2004
UNII:
59375N1D0U
Molecule Type:
Small molecule
Molecular Formula:
C10H20CaN2O8S2
Molecular Weight:
400.49
AlogP:
-0.6
PSA:
83.47
HBD:
2.0
HBA:
#RotB:
4.0
Source:
TIOTROPIUM
(2004)
Small molecule
Unknown
Unknown
Approved
Unknown
TIOTROPIUM
×
Maximum Phase:
4
First Approval:
2004
UNII:
0EB439235F
Molecule Type:
Small molecule
Molecular Formula:
C19H22NO4S2+
Molecular Weight:
392.52
AlogP:
2.35
PSA:
59.06
HBD:
1.0
HBA:
#RotB:
4.0
Source:
PEMETREXED DISODIUM
(2004)
Small molecule
Dihydrofolate reductase inhibitor
INJECTION; INTRAVENOUS
Approved
Carcinoma, Non-Small-Cell Lung
PEMETREXED DISODIUM
×
Maximum Phase:
4
First Approval:
2004
UNII:
2PKU919BA9
Molecule Type:
Small molecule
Molecular Formula:
C20H19N5Na2O6
Molecular Weight:
471.38
AlogP:
0.67
PSA:
191.26
HBD:
6.0
HBA:
#RotB:
9.0
Source:
GLUTAMINE
(2004)
Small molecule
Unknown
Unknown
Approved
Anemia, Sickle Cell; Short Bowel Syndrome
GLUTAMINE
×
Maximum Phase:
4
First Approval:
2004
UNII:
0RH81L854J
Molecule Type:
Small molecule
Molecular Formula:
C5H10N2O3
Molecular Weight:
146.15
AlogP:
-1.34
PSA:
106.41
HBD:
3.0
HBA:
#RotB:
4.0
Source:
BISACODYL
(2004)
Small molecule
Unknown
Unknown
Approved
Constipation
BISACODYL
×
Maximum Phase:
4
First Approval:
2004
UNII:
10X0709Y6I
Molecule Type:
Small molecule
Molecular Formula:
C22H19NO4
Molecular Weight:
361.4
AlogP:
4.11
PSA:
65.49
HBD:
0.0
HBA:
#RotB:
5.0
Source:
RIFAXIMIN
(2004)
Small molecule
Bacterial DNA-directed RNA polymerase inhibitor
ORAL
Approved
Diarrhea; Hepatic Encephalopathy; Infections
RIFAXIMIN
×
Maximum Phase:
4
First Approval:
2004
UNII:
L36O5T016N
Molecule Type:
Small molecule
Molecular Formula:
C43H51N3O11
Molecular Weight:
785.89
AlogP:
6.16
PSA:
198.38
HBD:
5.0
HBA:
#RotB:
2.0
Source:
PEMETREXED
(2004)
Small molecule
Unknown
INJECTION; INTRAVENOUS; IV (INFUSION)
Approved
Mesothelioma; Neoplasms
PEMETREXED
×
Maximum Phase:
4
First Approval:
2004
UNII:
04Q9AIZ7NO
Molecule Type:
Small molecule
Molecular Formula:
C20H21N5O6
Molecular Weight:
427.42
AlogP:
0.67
PSA:
191.26
HBD:
6.0
HBA:
#RotB:
9.0
Source:
PENTETATE ZINC TRISODIUM
(2004)
Small molecule
Radioactive metals chelating agent
INHALATION; INTRAVENOUS
Approved
Unknown
PENTETATE ZINC TRISODIUM
×
Maximum Phase:
4
First Approval:
2004
UNII:
NXU65IC8PG
Molecule Type:
Small molecule
Molecular Formula:
C14H18N3Na3O10Zn
Molecular Weight:
522.67
AlogP:
-2.68
PSA:
196.22
HBD:
5.0
HBA:
#RotB:
16.0
Source:
ERLOTINIB HYDROCHLORIDE
(2004)
Small molecule
Epidermal growth factor receptor erbB1 inhibitor
ORAL
Approved
Carcinoma, Non-Small-Cell Lung
ERLOTINIB HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2004
UNII:
DA87705X9K
Molecule Type:
Small molecule
Molecular Formula:
C22H24ClN3O4
Molecular Weight:
429.9
AlogP:
3.41
PSA:
74.73
HBD:
1.0
HBA:
#RotB:
10.0
Source:
1
2
…
53
54
55
56
57
58
59
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA